The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan/cetuximab.
Mario Scartozzi
Disclosure not yet available
Alessandra Mandolesi
Disclosure not yet available
Riccardo Giampieri
Disclosure not yet available
Alberto Zaniboni
Disclosure not yet available
Eva Galizia
Disclosure not yet available
Lucio Giustini
Disclosure not yet available
Rosa Rita Silva
Disclosure not yet available
Rossana Berardi
Disclosure not yet available
Italo Bearzi
Disclosure not yet available
Stefano Cascinu
Disclosure not yet available